Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 28, 2014; 20(36): 13088-13104
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13088
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13088
Specificity | Host | Isotype | Use | Dilution | Samples | Source (Catalog No.) |
Primary antibodies | ||||||
OPNK20 (SPP1) | Goat | Polyclonal IgG | WB | 1:1000 | Human, LX2 | Santa Cruz, Santa Cruz, CA, United States (sc-10591) |
Blocking | 200 ìg/mL | |||||
OPN (AF808) | Goat | Polyclonal IgG | WB | 1:1000 | Mice | RD (AF808) |
Capture anti-OPN | Mouse | Monoclonal | ELISA | 3 ìg/mL | Human, LX2 | RD (MAB14331) |
Detection biotynlated anti-OPN | Goat | Polyclonal IgG | ELISA | 200 ng/mL | Human, LX2 | RD (BAF1433) |
OPN-R3 aptamer blocks SPP1 binding to receptors | 100 nmol/L | LX2 | Duke University, NC, United States | |||
αvβ3-integrin (CD51/61) (ITGAV) | Mouse | Monoclonal | Blocking | 10 ìg/mL | LX2 | RD, Minneapolis, MN, United States (MAB3050) |
CD44v6 | Mouse | Monoclonal IgG1 | Blcoking | 1:1000 | LX2 | RD (BBA13) |
Vimentin | Rat | Monoclonal | IF | 1:200 | LX2 | RD (MAB2105) |
Phospho-Akt Ser473 (P-Akt) | Rabbit | Polyclonal | WB | 1:1000 | LX2, Mice | Cell Signalling Technology (No. 9271) |
Total-Akt (pan) | Rabbit | Polyclonal IgG | WB | 1:1000 | LX2, Mice | Cell Signalling Technology (No. 4691) |
Phospho-Erk p44/42 (P-Erk) | Mouse | Monoclonal IgG | WB | 1:2000 | LX2, Mice | Cell Signalling Technology, Danvers, MA, United States (No. 9106) |
Total-Erk (T-Erk) | Rabbit | Polyclonal | WB | 1:1000 | LX2, Mice | Cell Signalling Technology (No. 9102) |
GAPDH | Mouse | Monoclonal | WB | 1:200000 | Mice | Ambion (AM4300) |
Secondary antibodies | ||||||
Anti-mouse HRP (P0161) | 1:10000 | Dako Australia Pty Ltd, Campbellfield, VIC, Australia | ||||
Anti-rabbit HRP (P0449) | 1:7500 | |||||
Anti-goat HRP (P0448) | 1:75000 | |||||
AlexaFluor 488; AlexaFluor 594 | 1:400 | Molecular probes |
-
Citation: Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Osteopontin is an important mediator of alcoholic liver disease
via hepatic stellate cell activation. World J Gastroenterol 2014; 20(36): 13088-13104 - URL: https://www.wjgnet.com/1007-9327/full/v20/i36/13088.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i36.13088